International Society for Pharmacoepidemiology EIN 41-1688677

International Society for Pharmacoepidemiology

EIN  41-1688677 Public charity (501(c)(3)) Washington, DC Founded 1989
Form 990 (PDF) Compare with another nonprofit →
Verified accurate 9/1/26 · see original filing: IRS
Is this your organization?
Claim this profile to manage it and share your story.
Claim
Provided by the organization

This section is blank until International Society for Pharmacoepidemiology claims this page.

Know this organization? Claim it to add your story

Size
$1–10M
What they do
a nonprofit
Leadership
Mette Norgaard · Director
Money in and out
$3.3M revenue, $3.8M expenses
Bottom line
62% program efficiency

International Society for Pharmacoepidemiology is a nonprofit based in Washington, DC, formed in 1989. For fiscal year 2024 it reported $3.3M in revenue, $3.8M in expenses, and $3.3M in net assets.Pt I

Where the money goes · FY2024
Total revenue
$3.3M
Pt VIII · Ln 12
Total expenses
$3.8M
Pt IX · Ln 25
Net assets
$3.3M
Pt X · Ln 32
Revenue less expenses (Pt I · Ln 19): −$573K
Where spending went · Part IX cols B–D
Program services $0.62 Management & general $0.38
Program efficiency
62%
of spending reaches programs▼ -28% vs prior filing year
Operating runway
11.0mo
months of highly liquid reserves at operating expense rate▼ -53% vs prior filing year
Surplus margin
-18%
revenue over expenses, this year▼ -182% vs prior filing year

Summary of the Filing

Part I · fiscal year 2024 · Form 990
Revenue
$3.3M
FY2024▲ +24%
Expenses
$3.8M
FY2024▲ +86%
Total assets
$4.0M
FY2024▼ -13%
Total liabilities
$716K
FY2024▼ -13%
Total revenue
$3.3M
Pt VIII · Ln 12
Total expenses
$3.8M
Pt IX · Ln 25
Net assets
$3.3M
Pt X · Ln 32
Revenue less expensesPt I · Ln 19−$573K
Total assetsPt X · Ln 16$4.0M
Program-expense ratioPt IX · col B62%
Voting members of governing bodyPt I · Ln 320
Independent voting membersPt I · Ln 420
Mission & Programs · Part III

Where the work happens

3 program services account for $2.4M of program spending, described in the organization's own filed words · FY2024.
01

Development and Management of Scientific Forums

1) convene an annual scientific forum (international conference on pharmacoepidemiology & therapeutic risk management - ICPE) where members of the discipline meet to network, present results of methodological investigations and studies in progress, discuss public health policy issues concerning pharmacoepidemiology, therapeutic risk…

$2.3Mprogram expense
02

The Societys Communications Program Delivers

1) a website with significant resources on the expanding science and practice of pharmacoepidemiology, and presents ISPEs goals and objectives to current/prospective members, and the general public; and 2) regular email updates to members on developments in pharmacoepidemiology, or about ISPE.

$24Kprogram expense
03

Publications

1) The Society provides a members-only subscription to Pharmacoepidemiology and Drug Safety, a leading scientific journal publishing definitive, peer-reviewed papers on the science and practice of pharmacoepidemiology; and 2) a Manuscript Initiative, which funds the development of resource documents focused on pharmacoepidemiology…

$15Kprogram expense

Run this program? Claim this org to tell your story

Identity & Classification

Form 990 Header · IRS Business Master File
Legal nameHdr · item CInternational Society for Pharmacoepidemiology
EINHdr · item D41-1688677
Principal addressHdr · item CWashington, DC
WebsiteHdr · item Jwww.pharmacoepi.org
Year of formationHdr · item L1989
State of legal domicileHdr · item MDC
Exempt statusHdr · item I501(c)(3) · active
NTEE classificationIRS BMFNonprofit
Ruling yearIRS BMFJul 1994

Governance & Policies

Part VI
Voting members of the governing bodyPt VI · Ln 1a20
Independent voting membersPt VI · Ln 1b20
Conflict-of-interest policyPt VI · Ln 12aYes
Whistleblower policyPt VI · Ln 13Yes
Document retention policyPt VI · Ln 14Yes
CEO/top-official compensation independently reviewedPt VI · Ln 15aYes
Family or business relationships among officers/directorsPt VI · Ln 2No

Officers, Directors & Key Employees

Part VII, Section A · reportable compensation
$0Pt VII · Sec A
$0Pt VII · Sec A
Executive Director Emeritus
$0Pt VII · Sec A
$0Pt VII · Sec A
$0Pt VII · Sec A
$0Pt VII · Sec A
Director
$0Pt VII · Sec A
$0Pt VII · Sec A
See International Society for Pharmacoepidemiology executive salaries →

Are you one of these people? Claim this org to confirm your role

Statement of Revenue

Part VIII
Program service revenue$3.1M · 96%
Investment income$125K · 4%
Program service revenue96%$3.1M
Investment income4%$125K
Total revenueLn 12$3.3M

Statement of Functional Expenses

Part IX · allocated across program, management, and fundraising
Allocation · columns B–D
Program services $0.62 Management & general $0.38
Program services62%$2.4M
Management & general38%$1.4M
Total functional expensesLn 25$3.8M

Balance Sheet

Part X · end of year
CashLn 1$416K
Total assetsLn 16$4.0M
Total liabilitiesLn 26$716K
Total net assetsLn 32$3.3M
Months of cash on handcomputed1.3

Financial Metrics

Form 990 · FY2024 · each ratio shown with the dollars behind it
Liquidity & Payout
Operating runway
Highly liquid reserves $3.5M · Operating expenses/yr $3.8M
11.0 months
Where the money goes
Program services
Program services $2.4M · Total expenses $3.8M
62%
Management & General
Management & general $1.4M · Total expenses $3.8M
38%
Fundraising
Fundraising $0 · Total expenses $3.8M
0%
Cost to raise $1
Fundraising expense (3-yr avg) $0 · Solicited contributions (3-yr avg) $0
Solicited contributions below reporting floor
Where the money comes from
Contribution dependence
Contributions & grants $0 · Total revenue $3.3M
0%
Government reliance
Government grants — · Total revenue $3.3M
Earned-income share
Program service revenue $3.1M · Total revenue $3.3M
96%
Investment reliance
Investment income $125K · Total revenue $3.3M
+4%
Program self-sufficiency
Program service revenue $3.1M · Total expenses $3.8M
82%
Growth & trend
Revenue growth (YoY)
This year $3.3M · Prior year $2.6M
+24%
Revenue CAGR
FY2020 $911K · FY2024 $3.3M
+37%
Net-asset trend (YoY)
End of year $3.3M · Beginning of year —
Beginning net assets not meaningfully positive — showing dollar change
Balance sheet
Surplus Margin
Revenue $3.3M · Expenses $3.8M
-18%
Liabilities-to-Assets
Total liabilities — · Total assets $4.0M
Net-asset ratio
Net assets $3.3M · Total assets $4.0M
82%
Marketable Investment Share
Publicly traded securities (Pt X, ln 11) $3.1M · Other securities (Pt X, ln 12) — · Total assets (Pt X, ln 16) $4.0M
78%
People & payroll
Highest Reported Total Compensation
Individual Mette Norgaard · Reported title Director · Highest reported compensation $0 · Total expenses $3.8M
0%
Personnel share
Salaries, benefits & payroll (Pt IX 5-10) — · Total expenses $3.8M
Peer comparison

Same NTEE category, revenue band, and state where available. Descriptive — not a grade.

MetricThis orgPeer medianPercentile
Program ratio 62%
Overhead ratio 38%
Revenue growth 24%

Straight from the Form 990 — descriptive, not an evaluation. A ratio is hidden when its base is zero or too small to be meaningful; the dollars are always shown.

Grants

Schedule I · this organization's grantmaking
Grants paid · 1 grant · $27K · 2024–2024
Unitemized GrantFY2024$26,874

Similar Organizations

Closest in mission — by what they do
See all organizations like International Society for Pharmacoepidemiology →

Compare

Search another nonprofit to view revenue, expenses, assets, key metrics, and leaders side by side

Filings & Schedule Manifest

Part IV
III · Programs I · Grants R · Related orgs G · Fundraising L · Interested persons A · Public support F · Foreign M · Noncash
FY2024$2.6M revenue · ⤓ 990 PDF
FY2023$2.4M revenue · ⤓ 990 PDF
FY2022$828K revenue · ⤓ 990 PDF
FY2021$911K revenue · ⤓ 990 PDF

Want to add your own materials alongside these filings? Claim this org

Sources

Every figure above is drawn from these filings
Form 990 e-file (XML) · FY2024IRS
Classification, formation year, addressIRS Business Master File
Names, privacy, and removal requests More

The names, titles, and compensation shown on this page are reproduced from IRS Form 990 filings, which are public records.

Philanthropy.org does not alter the content of those filings. All information appears exactly as reported by the filing organization for the tax year shown.

We publish only information contained in the public IRS filing — and less than the filing contains. Our profile pages do not display street addresses, telephone numbers, personal email addresses, or other personal contact information, even where the filing includes them.

Many people share the same name. A name shown on this page reflects only what one organization reported in one IRS filing for one tax year. It should not be interpreted as identifying any other individual with the same or a similar name.

If you are no longer affiliated with the organization, your name will generally stop appearing in future IRS filings once the organization no longer reports you. Pages for tax years in which you were reported remain published because those filings remain part of the public record.

Philanthropy.org does not alter or remove IRS filing records. Removing a page from this website would not remove the underlying IRS filing, which remains publicly available from the IRS and other publishers of the same information.

If you believe the IRS filing itself is inaccurate, corrections must be made by the filing organization or the IRS directly.

If you ARE the filing organization, claim this org and add context

Made it to the end? Claim this organization

All figures are derived from public IRS Form 990 filings and are presented without evaluation of any organization. philanthropy.org does not rate, score, or rank organizations, including the peer-cohort and compensation comparisons above.